

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thrombin receptor signaling pathway (GO:0070493) | 7.70977037 |
| 2 | protein neddylation (GO:0045116) | 7.68827758 |
| 3 | regulation of platelet activation (GO:0010543) | 6.71613674 |
| 4 | neutrophil activation involved in immune response (GO:0002283) | 6.56208907 |
| 5 | daunorubicin metabolic process (GO:0044597) | 6.47535637 |
| 6 | polyketide metabolic process (GO:0030638) | 6.47535637 |
| 7 | doxorubicin metabolic process (GO:0044598) | 6.47535637 |
| 8 | adenosine receptor signaling pathway (GO:0001973) | 5.94573099 |
| 9 | blood coagulation, intrinsic pathway (GO:0007597) | 5.88447445 |
| 10 | platelet aggregation (GO:0070527) | 5.62387406 |
| 11 | negative regulation of norepinephrine secretion (GO:0010700) | 5.62167841 |
| 12 | negative regulation of platelet activation (GO:0010544) | 5.55348387 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.51443571 |
| 14 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 5.10623420 |
| 15 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.03318771 |
| 16 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.98686063 |
| 17 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.93825311 |
| 18 | presynaptic membrane assembly (GO:0097105) | 4.92640732 |
| 19 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.87794374 |
| 20 | lipoxygenase pathway (GO:0019372) | 4.80419536 |
| 21 | startle response (GO:0001964) | 4.80121187 |
| 22 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.73894813 |
| 23 | regulation of integrin activation (GO:0033623) | 4.59335917 |
| 24 | platelet degranulation (GO:0002576) | 4.50547613 |
| 25 | presynaptic membrane organization (GO:0097090) | 4.47414011 |
| 26 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.46357859 |
| 27 | regulation of lipoprotein metabolic process (GO:0050746) | 4.42170607 |
| 28 | angiogenesis involved in wound healing (GO:0060055) | 4.38307092 |
| 29 | response to pheromone (GO:0019236) | 4.37809796 |
| 30 | regulation of homotypic cell-cell adhesion (GO:0034110) | 4.36068297 |
| 31 | negative regulation of protein localization to cell surface (GO:2000009) | 4.23324685 |
| 32 | serotonin receptor signaling pathway (GO:0007210) | 4.22442411 |
| 33 | polyamine biosynthetic process (GO:0006596) | 4.20174155 |
| 34 | low-density lipoprotein particle remodeling (GO:0034374) | 4.16788977 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 4.14591976 |
| 36 | positive regulation of hemostasis (GO:1900048) | 4.01518994 |
| 37 | positive regulation of blood coagulation (GO:0030194) | 4.01518994 |
| 38 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.97000013 |
| 39 | platelet activation (GO:0030168) | 3.96801156 |
| 40 | positive regulation of macrophage differentiation (GO:0045651) | 3.94921613 |
| 41 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.93889119 |
| 42 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 3.92579192 |
| 43 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 3.92579192 |
| 44 | neuron cell-cell adhesion (GO:0007158) | 3.92563191 |
| 45 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.89029039 |
| 46 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.88080126 |
| 47 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.86628651 |
| 48 | postsynaptic membrane organization (GO:0001941) | 3.81533127 |
| 49 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.78860459 |
| 50 | homotypic cell-cell adhesion (GO:0034109) | 3.77049384 |
| 51 | megakaryocyte development (GO:0035855) | 3.75945650 |
| 52 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.74464241 |
| 53 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.70652926 |
| 54 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.69388699 |
| 55 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.68668059 |
| 56 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.68102519 |
| 57 | relaxation of smooth muscle (GO:0044557) | 3.64781319 |
| 58 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.62816401 |
| 59 | positive regulation of receptor recycling (GO:0001921) | 3.62758825 |
| 60 | synaptic transmission, glutamatergic (GO:0035249) | 3.60844429 |
| 61 | platelet formation (GO:0030220) | 3.59411119 |
| 62 | regulation of norepinephrine secretion (GO:0014061) | 3.59108429 |
| 63 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.59029764 |
| 64 | inner ear receptor stereocilium organization (GO:0060122) | 3.58952491 |
| 65 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.58936139 |
| 66 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.58899620 |
| 67 | positive regulation of coagulation (GO:0050820) | 3.57812578 |
| 68 | neutrophil activation (GO:0042119) | 3.56737225 |
| 69 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.53859614 |
| 70 | negative regulation of catecholamine secretion (GO:0033604) | 3.52278087 |
| 71 | purinergic receptor signaling pathway (GO:0035587) | 3.45340807 |
| 72 | extracellular fibril organization (GO:0043206) | 3.45186592 |
| 73 | auditory receptor cell stereocilium organization (GO:0060088) | 3.44423930 |
| 74 | beta-amyloid metabolic process (GO:0050435) | 3.43932345 |
| 75 | vocalization behavior (GO:0071625) | 3.38339401 |
| 76 | negative regulation of neurotransmitter transport (GO:0051589) | 3.36633695 |
| 77 | regulation of endothelial cell differentiation (GO:0045601) | 3.36524970 |
| 78 | drinking behavior (GO:0042756) | 3.35771603 |
| 79 | extracellular regulation of signal transduction (GO:1900115) | 3.32056442 |
| 80 | extracellular negative regulation of signal transduction (GO:1900116) | 3.32056442 |
| 81 | negative regulation of mast cell activation (GO:0033004) | 3.30746664 |
| 82 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.30304077 |
| 83 | negative regulation of muscle contraction (GO:0045932) | 3.30184469 |
| 84 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.29953081 |
| 85 | opioid receptor signaling pathway (GO:0038003) | 3.28964181 |
| 86 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.28432642 |
| 87 | urinary tract smooth muscle contraction (GO:0014848) | 3.26955763 |
| 88 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.26613783 |
| 89 | regulation of blood coagulation (GO:0030193) | 3.23364362 |
| 90 | regulation of hemostasis (GO:1900046) | 3.23364362 |
| 91 | cell differentiation involved in metanephros development (GO:0072202) | 3.21887882 |
| 92 | negative regulation of T cell apoptotic process (GO:0070233) | 3.21500219 |
| 93 | dopamine transport (GO:0015872) | 3.19651107 |
| 94 | relaxation of muscle (GO:0090075) | 3.19540297 |
| 95 | phospholipid homeostasis (GO:0055091) | 3.17475152 |
| 96 | detection of molecule of bacterial origin (GO:0032490) | 3.15508561 |
| 97 | neuron-neuron synaptic transmission (GO:0007270) | 3.15240673 |
| 98 | activation of protein kinase A activity (GO:0034199) | 3.14543711 |
| 99 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 3.12294416 |
| 100 | cyclooxygenase pathway (GO:0019371) | 3.11278813 |
| 101 | nonmotile primary cilium assembly (GO:0035058) | 3.10907926 |
| 102 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.10650022 |
| 103 | granulocyte activation (GO:0036230) | 3.09855051 |
| 104 | regulation of female receptivity (GO:0045924) | 3.09809757 |
| 105 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.08368164 |
| 106 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.07624416 |
| 107 | positive regulation of heat generation (GO:0031652) | 3.07368135 |
| 108 | sleep (GO:0030431) | 3.06080817 |
| 109 | glutamate receptor signaling pathway (GO:0007215) | 3.04194727 |
| 110 | regulation of receptor recycling (GO:0001919) | 3.01922463 |
| 111 | termination of signal transduction (GO:0023021) | 3.01844425 |
| 112 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.99089721 |
| 113 | high-density lipoprotein particle remodeling (GO:0034375) | 2.98444310 |
| 114 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.97892231 |
| 115 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.97892231 |
| 116 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.97256871 |
| 117 | mitochondrial calcium ion transport (GO:0006851) | 2.97031912 |
| 118 | positive regulation of synapse assembly (GO:0051965) | 2.96174102 |
| 119 | regulation of cholesterol efflux (GO:0010874) | 2.95919718 |
| 120 | energy homeostasis (GO:0097009) | 2.94078477 |
| 121 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.94077114 |
| 122 | L-phenylalanine catabolic process (GO:0006559) | 2.94077114 |
| 123 | negative regulation of stress fiber assembly (GO:0051497) | 2.92638700 |
| 124 | kidney morphogenesis (GO:0060993) | 2.92071621 |
| 125 | regulation of coagulation (GO:0050818) | 2.90528320 |
| 126 | reverse cholesterol transport (GO:0043691) | 2.89847722 |
| 127 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.88615808 |
| 128 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.88291080 |
| 129 | regulation of fever generation (GO:0031620) | 2.86533956 |
| 130 | histone H3-K4 trimethylation (GO:0080182) | 2.85799076 |
| 131 | aggressive behavior (GO:0002118) | 2.85543906 |
| 132 | plasma membrane fusion (GO:0045026) | 2.85378189 |
| 133 | autophagic vacuole fusion (GO:0000046) | 2.83514803 |
| 134 | cell differentiation involved in kidney development (GO:0061005) | 2.83065019 |
| 135 | reflex (GO:0060004) | 2.81730314 |
| 136 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.80776441 |
| 137 | regulation of memory T cell differentiation (GO:0043380) | 2.79641083 |
| 138 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.79506493 |
| 139 | amine biosynthetic process (GO:0009309) | 2.78762824 |
| 140 | cardiolipin metabolic process (GO:0032048) | 2.78341869 |
| 141 | vesicle targeting (GO:0006903) | 2.78122348 |
| 142 | dentate gyrus development (GO:0021542) | 2.77092583 |
| 143 | monoamine transport (GO:0015844) | 2.76858366 |
| 144 | regulation of synapse maturation (GO:0090128) | 2.76761191 |
| 145 | fibril organization (GO:0097435) | 2.76108609 |
| 146 | skeletal muscle tissue regeneration (GO:0043403) | 2.75432172 |
| 147 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.75006970 |
| 148 | positive regulation of muscle hypertrophy (GO:0014742) | 2.75006970 |
| 149 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.71603828 |
| 150 | regulation of DNA endoreduplication (GO:0032875) | 2.68511672 |
| 151 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.68498852 |
| 152 | mannosylation (GO:0097502) | 2.68411869 |
| 153 | mechanosensory behavior (GO:0007638) | 2.67811633 |
| 154 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.66225775 |
| 155 | neuronal action potential propagation (GO:0019227) | 2.64311474 |
| 156 | cytochrome complex assembly (GO:0017004) | 2.62867981 |
| 157 | regulation of timing of cell differentiation (GO:0048505) | 2.60658955 |
| 158 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.60320417 |
| 159 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.60219297 |
| 160 | forebrain neuron differentiation (GO:0021879) | 2.59237142 |
| 161 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.59208776 |
| 162 | positive regulation of action potential (GO:0045760) | 2.58753887 |
| 163 | prostate gland growth (GO:0060736) | 2.58234880 |
| 164 | DNA strand renaturation (GO:0000733) | 2.57843342 |
| 165 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.57047012 |
| 166 | mesenchymal cell differentiation (GO:0048762) | 2.56930394 |
| 167 | negative regulation of stem cell proliferation (GO:2000647) | 2.56738495 |
| 168 | superoxide anion generation (GO:0042554) | 2.56454822 |
| 169 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.53269220 |
| 170 | regulation of respiratory system process (GO:0044065) | 2.52860040 |
| 171 | phagosome maturation (GO:0090382) | 2.52638926 |
| 172 | developmental pigmentation (GO:0048066) | 2.52374147 |
| 173 | righting reflex (GO:0060013) | 2.51379698 |
| 174 | detection of calcium ion (GO:0005513) | 2.51270464 |
| 175 | protein localization to cilium (GO:0061512) | 2.50003541 |
| 176 | cellular anion homeostasis (GO:0030002) | 2.49510983 |
| 177 | response to cocaine (GO:0042220) | 2.48997612 |
| 178 | G-protein coupled receptor internalization (GO:0002031) | 2.48224756 |
| 179 | response to auditory stimulus (GO:0010996) | 2.47916348 |
| 180 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.46615467 |
| 181 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.46571213 |
| 182 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.46571213 |
| 183 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.44971857 |
| 184 | cranial nerve structural organization (GO:0021604) | 2.44568641 |
| 185 | limb bud formation (GO:0060174) | 2.42817224 |
| 186 | negative regulation of T cell mediated immunity (GO:0002710) | 2.40935435 |
| 187 | regulation of synapse assembly (GO:0051963) | 2.38462637 |
| 188 | regulation of activation of Janus kinase activity (GO:0010533) | 2.36627906 |
| 189 | regulation of platelet aggregation (GO:0090330) | 2.36168419 |
| 190 | auditory behavior (GO:0031223) | 2.35964935 |
| 191 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.35438360 |
| 192 | facial nerve structural organization (GO:0021612) | 2.33784340 |
| 193 | pyrimidine dimer repair (GO:0006290) | 2.33738924 |
| 194 | behavioral response to ethanol (GO:0048149) | 2.33207336 |
| 195 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.32544131 |
| 196 | tRNA methylation (GO:0030488) | 2.31933702 |
| 197 | cell proliferation in forebrain (GO:0021846) | 2.31361091 |
| 198 | transferrin transport (GO:0033572) | 2.31360099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.92283446 |
| 2 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.74829144 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.30326261 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.87128229 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.83407336 |
| 6 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.00713738 |
| 7 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.94292255 |
| 8 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.78631105 |
| 9 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.74474110 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.71324324 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.70164971 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.67341745 |
| 13 | GATA1_19941826_ChIP-Seq_K562_Human | 2.63438597 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.56021888 |
| 15 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.54465295 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.52592095 |
| 17 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.50407573 |
| 18 | GATA2_19941826_ChIP-Seq_K562_Human | 2.40246087 |
| 19 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.39396181 |
| 20 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.36081803 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.35425327 |
| 22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.35291233 |
| 23 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.32479765 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.31165244 |
| 25 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28109175 |
| 26 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.27807145 |
| 27 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.25878723 |
| 28 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.25429532 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.23845075 |
| 30 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.21980824 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.18644247 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.15195470 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.14161543 |
| 34 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.11401129 |
| 35 | P300_19829295_ChIP-Seq_ESCs_Human | 2.11088387 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.09137693 |
| 37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.06064737 |
| 38 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.03492717 |
| 39 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.00691735 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.98189567 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.97979233 |
| 42 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97692386 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.92876141 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.91355437 |
| 45 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.88877821 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88712077 |
| 47 | SPI1_23127762_ChIP-Seq_K562_Human | 1.87124980 |
| 48 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.87047865 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.86730586 |
| 50 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.85416779 |
| 51 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.84673140 |
| 52 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.83222497 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.80447162 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.80447162 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.79704368 |
| 56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.78804390 |
| 57 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72835425 |
| 58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.71460539 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.71185530 |
| 60 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.71135328 |
| 61 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.71134977 |
| 62 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.69146629 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.69040269 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.68908130 |
| 65 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.65363011 |
| 66 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64014351 |
| 67 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62124008 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.62087285 |
| 69 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.60101816 |
| 70 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.60044595 |
| 71 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59579704 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.58111062 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.56249260 |
| 74 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.55623885 |
| 75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.55228968 |
| 76 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.54880416 |
| 77 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.54786597 |
| 78 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.54533168 |
| 79 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.53778901 |
| 80 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52023703 |
| 81 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.51400583 |
| 82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.51382251 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.51382251 |
| 84 | EWS_26573619_Chip-Seq_HEK293_Human | 1.49030535 |
| 85 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.48865925 |
| 86 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.48178653 |
| 87 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47607214 |
| 88 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45254166 |
| 89 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.45201960 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44680598 |
| 91 | VDR_22108803_ChIP-Seq_LS180_Human | 1.44480241 |
| 92 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.42937190 |
| 93 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42905146 |
| 94 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.41159270 |
| 95 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.40559839 |
| 96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39435818 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38889538 |
| 98 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.38729002 |
| 99 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.38082562 |
| 100 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.37380646 |
| 101 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.37089105 |
| 102 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36152070 |
| 103 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.34935613 |
| 104 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34844474 |
| 105 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33673790 |
| 106 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.33535001 |
| 107 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.32872993 |
| 108 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.30780545 |
| 109 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28813533 |
| 110 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.28307284 |
| 111 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.26700291 |
| 112 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26182460 |
| 113 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25595886 |
| 114 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.25093867 |
| 115 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.24763322 |
| 116 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.24685507 |
| 117 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24453507 |
| 118 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24337172 |
| 119 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24121692 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 1.21677626 |
| 121 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21505407 |
| 122 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.21422088 |
| 123 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21398563 |
| 124 | TCF4_23295773_ChIP-Seq_U87_Human | 1.21267530 |
| 125 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21190025 |
| 126 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.20454237 |
| 127 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.20446298 |
| 128 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18209893 |
| 129 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.17895766 |
| 130 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.17163235 |
| 131 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16197332 |
| 132 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.15655562 |
| 133 | JUN_21703547_ChIP-Seq_K562_Human | 1.15526145 |
| 134 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.15032402 |
| 135 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.14851111 |
| 136 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.12616053 |
| 137 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.11285625 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11272554 |
| 139 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09788682 |
| 140 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08637650 |
| 141 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.08271722 |
| 142 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07012871 |
| 143 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.06876303 |
| 144 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.06675246 |
| 145 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.05094672 |
| 146 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.00843138 |
| 147 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.00301180 |
| 148 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99621070 |
| 149 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97980299 |
| 150 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96756701 |
| 151 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94385997 |
| 152 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.94203524 |
| 153 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93706397 |
| 154 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.89691371 |
| 155 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89645000 |
| 156 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89534330 |
| 157 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.86568810 |
| 158 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.83063895 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81546587 |
| 160 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.80281546 |
| 161 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.79326998 |
| 162 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79004853 |
| 163 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78572813 |
| 164 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.78393649 |
| 165 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77163262 |
| 166 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75934648 |
| 167 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.75306722 |
| 168 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.74657294 |
| 169 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.73904476 |
| 170 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.73351156 |
| 171 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.73234454 |
| 172 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.73234454 |
| 173 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.72982207 |
| 174 | CEBPB_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.72214235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 9.77684714 |
| 2 | MP0000566_synostosis | 4.58296263 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.38593889 |
| 4 | MP0004084_abnormal_cardiac_muscle | 3.38066186 |
| 5 | MP0000465_gastrointestinal_hemorrhage | 3.31763317 |
| 6 | MP0005646_abnormal_pituitary_gland | 3.08196061 |
| 7 | MP0005645_abnormal_hypothalamus_physiol | 3.04684608 |
| 8 | MP0001188_hyperpigmentation | 2.91276957 |
| 9 | MP0001986_abnormal_taste_sensitivity | 2.72238841 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.67784265 |
| 11 | MP0003880_abnormal_central_pattern | 2.64591882 |
| 12 | MP0002736_abnormal_nociception_after | 2.59849693 |
| 13 | MP0004130_abnormal_muscle_cell | 2.55932991 |
| 14 | MP0002277_abnormal_respiratory_mucosa | 2.54274122 |
| 15 | MP0005083_abnormal_biliary_tract | 2.51539442 |
| 16 | MP0000343_altered_response_to | 2.50136000 |
| 17 | MP0005171_absent_coat_pigmentation | 2.49907855 |
| 18 | MP0002163_abnormal_gland_morphology | 2.45001092 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.41476793 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.41406380 |
| 21 | MP0003787_abnormal_imprinting | 2.35913138 |
| 22 | MP0003303_peritoneal_inflammation | 2.22121991 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 2.19353529 |
| 24 | MP0000230_abnormal_systemic_arterial | 2.16118064 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.11685463 |
| 26 | MP0003566_abnormal_cell_adhesion | 2.09664071 |
| 27 | MP0005379_endocrine/exocrine_gland_phen | 2.09097745 |
| 28 | MP0002638_abnormal_pupillary_reflex | 2.06031554 |
| 29 | MP0009697_abnormal_copulation | 2.05610286 |
| 30 | MP0003941_abnormal_skin_development | 2.04588530 |
| 31 | MP0009745_abnormal_behavioral_response | 2.03255655 |
| 32 | MP0001486_abnormal_startle_reflex | 1.99636426 |
| 33 | MP0001502_abnormal_circadian_rhythm | 1.97700806 |
| 34 | MP0008775_abnormal_heart_ventricle | 1.87316111 |
| 35 | MP0003828_pulmonary_edema | 1.83459227 |
| 36 | MP0002572_abnormal_emotion/affect_behav | 1.83329152 |
| 37 | MP0001879_abnormal_lymphatic_vessel | 1.80183854 |
| 38 | MP0009046_muscle_twitch | 1.76539656 |
| 39 | MP0004215_abnormal_myocardial_fiber | 1.74541331 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.72631064 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.72426312 |
| 42 | MP0002064_seizures | 1.69991230 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.69339025 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.66983811 |
| 45 | MP0005409_darkened_coat_color | 1.66754849 |
| 46 | MP0003635_abnormal_synaptic_transmissio | 1.66726131 |
| 47 | MP0004742_abnormal_vestibular_system | 1.65694082 |
| 48 | MP0003638_abnormal_response/metabolism_ | 1.64146150 |
| 49 | MP0008004_abnormal_stomach_pH | 1.59432644 |
| 50 | MP0008872_abnormal_physiological_respon | 1.59320752 |
| 51 | MP0005257_abnormal_intraocular_pressure | 1.59060895 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 1.57237167 |
| 53 | MP0004859_abnormal_synaptic_plasticity | 1.55788149 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.55425531 |
| 55 | MP0002063_abnormal_learning/memory/cond | 1.54303183 |
| 56 | MP0001851_eye_inflammation | 1.50566723 |
| 57 | MP0000015_abnormal_ear_pigmentation | 1.50420187 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.49003492 |
| 59 | MP0001835_abnormal_antigen_presentation | 1.47018779 |
| 60 | MP0002272_abnormal_nervous_system | 1.46074167 |
| 61 | MP0005410_abnormal_fertilization | 1.44266591 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.42167727 |
| 63 | MP0001984_abnormal_olfaction | 1.42105140 |
| 64 | MP0004484_altered_response_of | 1.36534441 |
| 65 | MP0003878_abnormal_ear_physiology | 1.36074192 |
| 66 | MP0005377_hearing/vestibular/ear_phenot | 1.36074192 |
| 67 | MP0002972_abnormal_cardiac_muscle | 1.35418380 |
| 68 | MP0005058_abnormal_lysosome_morphology | 1.33538750 |
| 69 | MP0010329_abnormal_lipoprotein_level | 1.33182572 |
| 70 | MP0000249_abnormal_blood_vessel | 1.31639016 |
| 71 | MP0000631_abnormal_neuroendocrine_gland | 1.30969949 |
| 72 | MP0002822_catalepsy | 1.29414405 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.25932579 |
| 74 | MP0008874_decreased_physiological_sensi | 1.25272071 |
| 75 | MP0000678_abnormal_parathyroid_gland | 1.25088841 |
| 76 | MP0002249_abnormal_larynx_morphology | 1.21913004 |
| 77 | MP0002184_abnormal_innervation | 1.21820172 |
| 78 | MP0006138_congestive_heart_failure | 1.21323799 |
| 79 | MP0005620_abnormal_muscle_contractility | 1.20244578 |
| 80 | MP0005670_abnormal_white_adipose | 1.19213892 |
| 81 | MP0003136_yellow_coat_color | 1.19069759 |
| 82 | MP0010155_abnormal_intestine_physiology | 1.17794165 |
| 83 | MP0002734_abnormal_mechanical_nocicepti | 1.17439857 |
| 84 | MP0000778_abnormal_nervous_system | 1.16700139 |
| 85 | MP0001905_abnormal_dopamine_level | 1.14817071 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 1.14668153 |
| 87 | MP0000049_abnormal_middle_ear | 1.13327865 |
| 88 | MP0001545_abnormal_hematopoietic_system | 1.11422134 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 1.11422134 |
| 90 | MP0001970_abnormal_pain_threshold | 1.11180013 |
| 91 | MP0001529_abnormal_vocalization | 1.10878315 |
| 92 | MP0002132_abnormal_respiratory_system | 1.09614775 |
| 93 | MP0005385_cardiovascular_system_phenoty | 1.09118962 |
| 94 | MP0001544_abnormal_cardiovascular_syste | 1.09118962 |
| 95 | MP0005000_abnormal_immune_tolerance | 1.08368524 |
| 96 | MP0008058_abnormal_DNA_repair | 1.08232288 |
| 97 | MP0004924_abnormal_behavior | 1.07747803 |
| 98 | MP0005386_behavior/neurological_phenoty | 1.07747803 |
| 99 | MP0002396_abnormal_hematopoietic_system | 1.07109218 |
| 100 | MP0002398_abnormal_bone_marrow | 1.04766525 |
| 101 | MP0008877_abnormal_DNA_methylation | 1.04657433 |
| 102 | MP0009763_increased_sensitivity_to | 1.04259769 |
| 103 | MP0001963_abnormal_hearing_physiology | 1.03705132 |
| 104 | MP0001663_abnormal_digestive_system | 1.03507978 |
| 105 | MP0005535_abnormal_body_temperature | 1.02271679 |
| 106 | MP0005165_increased_susceptibility_to | 1.00043292 |
| 107 | MP0000026_abnormal_inner_ear | 0.99173785 |
| 108 | MP0003879_abnormal_hair_cell | 0.97757774 |
| 109 | MP0003122_maternal_imprinting | 0.97672429 |
| 110 | MP0001440_abnormal_grooming_behavior | 0.97610960 |
| 111 | MP0003724_increased_susceptibility_to | 0.96955704 |
| 112 | MP0002733_abnormal_thermal_nociception | 0.96708063 |
| 113 | MP0000372_irregular_coat_pigmentation | 0.95905602 |
| 114 | MP0004142_abnormal_muscle_tone | 0.95401179 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.95222577 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.93577787 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.93219607 |
| 118 | MP0010368_abnormal_lymphatic_system | 0.93163327 |
| 119 | MP0009642_abnormal_blood_homeostasis | 0.92661668 |
| 120 | MP0003186_abnormal_redox_activity | 0.90961456 |
| 121 | MP0004134_abnormal_chest_morphology | 0.90730833 |
| 122 | MP0009250_abnormal_appendicular_skeleto | 0.90432474 |
| 123 | MP0005551_abnormal_eye_electrophysiolog | 0.90341720 |
| 124 | MP0000858_altered_metastatic_potential | 0.90298697 |
| 125 | MP0003656_abnormal_erythrocyte_physiolo | 0.89060411 |
| 126 | MP0004947_skin_inflammation | 0.88639412 |
| 127 | MP0008569_lethality_at_weaning | 0.88468475 |
| 128 | MP0004133_heterotaxia | 0.88148434 |
| 129 | MP0000681_abnormal_thyroid_gland | 0.86538753 |
| 130 | MP0002118_abnormal_lipid_homeostasis | 0.85586375 |
| 131 | MP0002095_abnormal_skin_pigmentation | 0.83871906 |
| 132 | MP0001533_abnormal_skeleton_physiology | 0.81518010 |
| 133 | MP0004510_myositis | 0.79444631 |
| 134 | MP0002128_abnormal_blood_circulation | 0.79119664 |
| 135 | MP0002102_abnormal_ear_morphology | 0.78902166 |
| 136 | MP0009379_abnormal_foot_pigmentation | 0.76449374 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.75776324 |
| 138 | MP0000516_abnormal_urinary_system | 0.75704209 |
| 139 | MP0005367_renal/urinary_system_phenotyp | 0.75704209 |
| 140 | MP0000689_abnormal_spleen_morphology | 0.73699108 |
| 141 | MP0002938_white_spotting | 0.73619801 |
| 142 | MP0001177_atelectasis | 0.73519105 |
| 143 | MP0005671_abnormal_response_to | 0.73354285 |
| 144 | MP0001756_abnormal_urination | 0.73290149 |
| 145 | MP0003075_altered_response_to | 0.72955235 |
| 146 | MP0004085_abnormal_heartbeat | 0.72923250 |
| 147 | MP0004270_analgesia | 0.72823316 |
| 148 | MP0002723_abnormal_immune_serum | 0.72162131 |
| 149 | MP0002751_abnormal_autonomic_nervous | 0.70823845 |
| 150 | MP0009765_abnormal_xenobiotic_induced | 0.70800060 |
| 151 | MP0009764_decreased_sensitivity_to | 0.70423837 |
| 152 | MP0005248_abnormal_Harderian_gland | 0.70047450 |
| 153 | MP0003121_genomic_imprinting | 0.69287382 |
| 154 | MP0002116_abnormal_craniofacial_bone | 0.68349047 |
| 155 | MP0001800_abnormal_humoral_immune | 0.68056488 |
| 156 | MP0005365_abnormal_bile_salt | 0.67164561 |
| 157 | MP0002429_abnormal_blood_cell | 0.66646133 |
| 158 | MP0003385_abnormal_body_wall | 0.65896233 |
| 159 | MP0003011_delayed_dark_adaptation | 0.65748791 |
| 160 | MP0003866_abnormal_defecation | 0.64353637 |
| 161 | MP0005381_digestive/alimentary_phenotyp | 0.64283278 |
| 162 | MP0001664_abnormal_digestion | 0.62726720 |
| 163 | MP0002452_abnormal_antigen_presenting | 0.62676654 |
| 164 | MP0005253_abnormal_eye_physiology | 0.62415826 |
| 165 | MP0002066_abnormal_motor_capabilities/c | 0.61708658 |
| 166 | MP0003300_gastrointestinal_ulcer | 0.61401807 |
| 167 | MP0000955_abnormal_spinal_cord | 0.60815651 |
| 168 | MP0002722_abnormal_immune_system | 0.60204481 |
| 169 | MP0008057_abnormal_DNA_replication | 0.60054663 |
| 170 | MP0002148_abnormal_hypersensitivity_rea | 0.59986608 |
| 171 | MP0002998_abnormal_bone_remodeling | 0.59735190 |
| 172 | MP0001661_extended_life_span | 0.59240827 |
| 173 | MP0005174_abnormal_tail_pigmentation | 0.58420187 |
| 174 | MP0005501_abnormal_skin_physiology | 0.55625890 |
| 175 | MP0001845_abnormal_inflammatory_respons | 0.55588388 |
| 176 | MP0005375_adipose_tissue_phenotype | 0.55016090 |
| 177 | MP0005023_abnormal_wound_healing | 0.54460807 |
| 178 | MP0005085_abnormal_gallbladder_physiolo | 0.52408468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 9.55354587 |
| 2 | Purpura (HP:0000979) | 8.87186816 |
| 3 | Epistaxis (HP:0000421) | 7.47347730 |
| 4 | Gingival bleeding (HP:0000225) | 6.34705795 |
| 5 | Impaired platelet aggregation (HP:0003540) | 6.03028587 |
| 6 | Abnormal platelet function (HP:0011869) | 6.03028587 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 6.01566714 |
| 8 | Acanthocytosis (HP:0001927) | 4.18010095 |
| 9 | Spontaneous hematomas (HP:0007420) | 4.08497460 |
| 10 | Focal motor seizures (HP:0011153) | 4.08163945 |
| 11 | Poikilocytosis (HP:0004447) | 4.07211243 |
| 12 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.84865509 |
| 13 | Conjunctival telangiectasia (HP:0000524) | 3.75979133 |
| 14 | Febrile seizures (HP:0002373) | 3.75723191 |
| 15 | Dyschromatopsia (HP:0007641) | 3.69440354 |
| 16 | Abnormal pupillary function (HP:0007686) | 3.39815697 |
| 17 | Paralysis (HP:0003470) | 3.37715666 |
| 18 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.36476082 |
| 19 | Absent/shortened dynein arms (HP:0200106) | 3.36476082 |
| 20 | Chromsome breakage (HP:0040012) | 3.35788317 |
| 21 | Morphological abnormality of the middle ear (HP:0008609) | 3.29969100 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.17410118 |
| 23 | Bruising susceptibility (HP:0000978) | 3.16642817 |
| 24 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.16157546 |
| 25 | Abnormality of lateral ventricle (HP:0030047) | 3.11479151 |
| 26 | Chronic hepatic failure (HP:0100626) | 3.04859486 |
| 27 | Increased density of long bones (HP:0006392) | 2.98109755 |
| 28 | Abnormality of incisor morphology (HP:0011063) | 2.88875522 |
| 29 | Septo-optic dysplasia (HP:0100842) | 2.85231964 |
| 30 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.83752068 |
| 31 | Osteomalacia (HP:0002749) | 2.83130872 |
| 32 | Hyperventilation (HP:0002883) | 2.78919598 |
| 33 | Abnormal auditory evoked potentials (HP:0006958) | 2.76502323 |
| 34 | Abnormal hair whorl (HP:0010721) | 2.72880142 |
| 35 | True hermaphroditism (HP:0010459) | 2.70712520 |
| 36 | Cerebral palsy (HP:0100021) | 2.67232062 |
| 37 | Upper limb muscle weakness (HP:0003484) | 2.65168443 |
| 38 | Epileptic encephalopathy (HP:0200134) | 2.65023566 |
| 39 | Tubulointerstitial nephritis (HP:0001970) | 2.64981866 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.64811789 |
| 41 | Tented upper lip vermilion (HP:0010804) | 2.62138684 |
| 42 | Protruding tongue (HP:0010808) | 2.58546720 |
| 43 | Optic nerve hypoplasia (HP:0000609) | 2.57277418 |
| 44 | Limb dystonia (HP:0002451) | 2.51040906 |
| 45 | Nephrogenic diabetes insipidus (HP:0009806) | 2.47409778 |
| 46 | Follicular hyperkeratosis (HP:0007502) | 2.39769142 |
| 47 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.37434142 |
| 48 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.37434142 |
| 49 | Abnormal ciliary motility (HP:0012262) | 2.36692618 |
| 50 | Ventricular fibrillation (HP:0001663) | 2.35752461 |
| 51 | Pancreatic fibrosis (HP:0100732) | 2.35651593 |
| 52 | Abnormality of molar morphology (HP:0011070) | 2.34839010 |
| 53 | Abnormality of molar (HP:0011077) | 2.34839010 |
| 54 | Duplicated collecting system (HP:0000081) | 2.33220297 |
| 55 | Hepatosplenomegaly (HP:0001433) | 2.28320371 |
| 56 | Gait imbalance (HP:0002141) | 2.27574998 |
| 57 | Congenital primary aphakia (HP:0007707) | 2.26384921 |
| 58 | Joint hemorrhage (HP:0005261) | 2.25542611 |
| 59 | Xanthomatosis (HP:0000991) | 2.23543091 |
| 60 | Abnormality of dental color (HP:0011073) | 2.23426094 |
| 61 | Abnormality of the dental root (HP:0006486) | 2.23222330 |
| 62 | Taurodontia (HP:0000679) | 2.23222330 |
| 63 | Abnormality of permanent molar morphology (HP:0011071) | 2.23222330 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.22793011 |
| 65 | Hypoplasia of the fovea (HP:0007750) | 2.22780478 |
| 66 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.22780478 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.22211880 |
| 68 | Muscle fiber splitting (HP:0003555) | 2.20332117 |
| 69 | Nephronophthisis (HP:0000090) | 2.19357967 |
| 70 | Abnormality of the renal collecting system (HP:0004742) | 2.17745221 |
| 71 | Abnormality of the dental pulp (HP:0006479) | 2.17685021 |
| 72 | Retrobulbar optic neuritis (HP:0100654) | 2.17083696 |
| 73 | Optic neuritis (HP:0100653) | 2.17083696 |
| 74 | Bundle branch block (HP:0011710) | 2.14811068 |
| 75 | Absent eyebrow (HP:0002223) | 2.13870940 |
| 76 | Intestinal atresia (HP:0011100) | 2.13541530 |
| 77 | Papillary thyroid carcinoma (HP:0002895) | 2.12308845 |
| 78 | Tinnitus (HP:0000360) | 2.12252832 |
| 79 | Thyroid-stimulating hormone excess (HP:0002925) | 2.11847037 |
| 80 | Decreased central vision (HP:0007663) | 2.11561975 |
| 81 | Pancreatic cysts (HP:0001737) | 2.09609158 |
| 82 | Nemaline bodies (HP:0003798) | 2.08457912 |
| 83 | Joint swelling (HP:0001386) | 2.08323451 |
| 84 | Hyperthyroidism (HP:0000836) | 2.05343508 |
| 85 | Patchy hypopigmentation of hair (HP:0011365) | 2.04501734 |
| 86 | Spontaneous abortion (HP:0005268) | 2.03341495 |
| 87 | Conical tooth (HP:0000698) | 2.02867742 |
| 88 | Fibular aplasia (HP:0002990) | 2.01993983 |
| 89 | 3-Methylglutaconic aciduria (HP:0003535) | 2.01687072 |
| 90 | Preaxial hand polydactyly (HP:0001177) | 2.01013247 |
| 91 | Abnormality of the fovea (HP:0000493) | 2.00953853 |
| 92 | Atonic seizures (HP:0010819) | 2.00404269 |
| 93 | Prolonged bleeding time (HP:0003010) | 11.7393140 |
| 94 | Increased mean platelet volume (HP:0011877) | 10.8420144 |
| 95 | Menorrhagia (HP:0000132) | 10.5608854 |
| 96 | Abnormal platelet volume (HP:0011876) | 10.1287151 |
| 97 | Recurrent corneal erosions (HP:0000495) | 1.99781232 |
| 98 | Abnormality of the renal medulla (HP:0100957) | 1.96130212 |
| 99 | Occipital encephalocele (HP:0002085) | 1.95172743 |
| 100 | Hypothermia (HP:0002045) | 1.95083650 |
| 101 | Molar tooth sign on MRI (HP:0002419) | 1.94680329 |
| 102 | Abnormality of midbrain morphology (HP:0002418) | 1.94680329 |
| 103 | Abnormality of binocular vision (HP:0011514) | 1.94104274 |
| 104 | Diplopia (HP:0000651) | 1.94104274 |
| 105 | Nausea (HP:0002018) | 1.94081708 |
| 106 | Muscle fiber inclusion bodies (HP:0100299) | 1.93888998 |
| 107 | Stomach cancer (HP:0012126) | 1.92942683 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 1.92107547 |
| 109 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.91055344 |
| 110 | Tongue fasciculations (HP:0001308) | 1.90666523 |
| 111 | Alveolar cell carcinoma (HP:0006519) | 1.90308497 |
| 112 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.89380707 |
| 113 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.89225009 |
| 114 | Oligohydramnios (HP:0001562) | 1.88767678 |
| 115 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.87827114 |
| 116 | Abnormality of iron homeostasis (HP:0011031) | 1.87099538 |
| 117 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.86949746 |
| 118 | Male infertility (HP:0003251) | 1.86667833 |
| 119 | White forelock (HP:0002211) | 1.86641043 |
| 120 | Recurrent pneumonia (HP:0006532) | 1.85092186 |
| 121 | Distal lower limb amyotrophy (HP:0008944) | 1.84801348 |
| 122 | Stomatitis (HP:0010280) | 1.83879645 |
| 123 | Congenital sensorineural hearing impairment (HP:0008527) | 1.82180659 |
| 124 | Parakeratosis (HP:0001036) | 1.81980408 |
| 125 | Polycythemia (HP:0001901) | 1.81875474 |
| 126 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.81831284 |
| 127 | Renal dysplasia (HP:0000110) | 1.81731094 |
| 128 | Aganglionic megacolon (HP:0002251) | 1.81616698 |
| 129 | Astigmatism (HP:0000483) | 1.81538879 |
| 130 | Alopecia of scalp (HP:0002293) | 1.81120343 |
| 131 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.80286830 |
| 132 | Fibular hypoplasia (HP:0003038) | 1.80014323 |
| 133 | Growth hormone deficiency (HP:0000824) | 1.79174699 |
| 134 | J-shaped sella turcica (HP:0002680) | 1.79108731 |
| 135 | Fair hair (HP:0002286) | 1.78332666 |
| 136 | Muscle fibrillation (HP:0010546) | 1.78292723 |
| 137 | Hyperphosphatemia (HP:0002905) | 1.76945517 |
| 138 | Aplasia cutis congenita (HP:0001057) | 1.74988555 |
| 139 | Generalized hypopigmentation of hair (HP:0011358) | 1.73587835 |
| 140 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.73385904 |
| 141 | Prostate neoplasm (HP:0100787) | 1.72474772 |
| 142 | Large eyes (HP:0001090) | 1.72199587 |
| 143 | Poor coordination (HP:0002370) | 1.72143123 |
| 144 | Duplication of thumb phalanx (HP:0009942) | 1.72006010 |
| 145 | Clubbing of toes (HP:0100760) | 1.71083982 |
| 146 | Abnormality of the septum pellucidum (HP:0007375) | 1.70946561 |
| 147 | Corneal dystrophy (HP:0001131) | 1.70162023 |
| 148 | Genital tract atresia (HP:0001827) | 1.69549195 |
| 149 | Increased IgM level (HP:0003496) | 1.69410269 |
| 150 | Meckel diverticulum (HP:0002245) | 1.69371628 |
| 151 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.68775150 |
| 152 | Dysautonomia (HP:0002459) | 1.68760147 |
| 153 | Abnormality of the parietal bone (HP:0002696) | 1.68752118 |
| 154 | Biliary tract neoplasm (HP:0100574) | 1.68654663 |
| 155 | Absent septum pellucidum (HP:0001331) | 1.66858422 |
| 156 | Progressive sensorineural hearing impairment (HP:0000408) | 1.66727450 |
| 157 | Hyporeflexia of lower limbs (HP:0002600) | 1.63909279 |
| 158 | Myocardial infarction (HP:0001658) | 1.62186693 |
| 159 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.62066538 |
| 160 | Arterial thrombosis (HP:0004420) | 1.61010618 |
| 161 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.60902577 |
| 162 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.59710976 |
| 163 | Abnormality of alanine metabolism (HP:0010916) | 1.59710976 |
| 164 | Hyperalaninemia (HP:0003348) | 1.59710976 |
| 165 | Vertigo (HP:0002321) | 1.56589501 |
| 166 | Episodic fever (HP:0001954) | 1.56040332 |
| 167 | Abnormality of macrophages (HP:0004311) | 1.56008832 |
| 168 | Aortic aneurysm (HP:0004942) | 1.55795344 |
| 169 | Exercise-induced myalgia (HP:0003738) | 1.53173029 |
| 170 | Polyphagia (HP:0002591) | 1.50883327 |
| 171 | Lower limb amyotrophy (HP:0007210) | 1.49752619 |
| 172 | Central scotoma (HP:0000603) | 1.47726075 |
| 173 | Testicular neoplasm (HP:0010788) | 1.46681567 |
| 174 | Mitral stenosis (HP:0001718) | 1.45171558 |
| 175 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.44554428 |
| 176 | Basal ganglia calcification (HP:0002135) | 1.44415729 |
| 177 | Uterine leiomyosarcoma (HP:0002891) | 1.44404496 |
| 178 | Leiomyosarcoma (HP:0100243) | 1.44404496 |
| 179 | Increased serum ferritin (HP:0003281) | 1.44090322 |
| 180 | Abnormality of the prostate (HP:0008775) | 1.39494210 |
| 181 | Obstructive lung disease (HP:0006536) | 1.37962126 |
| 182 | Chronic obstructive pulmonary disease (HP:0006510) | 1.37962126 |
| 183 | Thyroid carcinoma (HP:0002890) | 1.37359081 |
| 184 | Insidious onset (HP:0003587) | 1.36164893 |
| 185 | Termporal pattern (HP:0011008) | 1.36164893 |
| 186 | Intellectual disability, profound (HP:0002187) | 1.35704004 |
| 187 | Back pain (HP:0003418) | 1.35221038 |
| 188 | Encephalitis (HP:0002383) | 1.35154177 |
| 189 | Hypomagnesemia (HP:0002917) | 1.34652312 |
| 190 | Areflexia of lower limbs (HP:0002522) | 1.34574363 |
| 191 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.32651265 |
| 192 | Increased variability in muscle fiber diameter (HP:0003557) | 1.31366356 |
| 193 | Arthropathy (HP:0003040) | 1.31156166 |
| 194 | Visual hallucinations (HP:0002367) | 1.30729309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.94536720 |
| 2 | MST4 | 4.32152572 |
| 3 | MAP2K7 | 4.18812295 |
| 4 | BMX | 4.12103064 |
| 5 | SIK3 | 3.87327610 |
| 6 | MYLK | 3.68634906 |
| 7 | TRIM28 | 3.40056476 |
| 8 | EIF2AK1 | 3.12536189 |
| 9 | PTK2B | 2.57752225 |
| 10 | BTK | 2.56883899 |
| 11 | MAP3K12 | 2.55470997 |
| 12 | PIK3CG | 2.48755055 |
| 13 | MKNK2 | 2.43327566 |
| 14 | TXK | 2.41434894 |
| 15 | SIK2 | 2.36155069 |
| 16 | BMPR1B | 2.23796624 |
| 17 | MAP3K4 | 2.23183865 |
| 18 | SGK2 | 2.18945915 |
| 19 | PRPF4B | 2.18922719 |
| 20 | STK16 | 2.14907588 |
| 21 | TNIK | 2.12151641 |
| 22 | CSF1R | 2.07716893 |
| 23 | NTRK3 | 2.03000157 |
| 24 | EPHA4 | 1.97960928 |
| 25 | CDK19 | 1.93577498 |
| 26 | CCNB1 | 1.88733187 |
| 27 | ILK | 1.88124499 |
| 28 | LMTK2 | 1.83823462 |
| 29 | TAOK3 | 1.83009184 |
| 30 | ZAP70 | 1.79065954 |
| 31 | ADRBK2 | 1.74588842 |
| 32 | ARAF | 1.69410669 |
| 33 | MAP3K14 | 1.67517944 |
| 34 | SRPK1 | 1.66892299 |
| 35 | BMPR2 | 1.64841431 |
| 36 | YES1 | 1.60593667 |
| 37 | BLK | 1.58547490 |
| 38 | ACVR1B | 1.54735807 |
| 39 | ZAK | 1.53824211 |
| 40 | CDK8 | 1.50117040 |
| 41 | STK3 | 1.45187712 |
| 42 | MAPKAPK3 | 1.43068653 |
| 43 | SGK223 | 1.37855030 |
| 44 | SGK494 | 1.37855030 |
| 45 | GRK6 | 1.33190148 |
| 46 | FGR | 1.32943724 |
| 47 | MAPK13 | 1.32581725 |
| 48 | MKNK1 | 1.32541996 |
| 49 | PNCK | 1.31190054 |
| 50 | SGK3 | 1.26100751 |
| 51 | MAP2K4 | 1.24690938 |
| 52 | PHKG1 | 1.23606246 |
| 53 | PHKG2 | 1.23606246 |
| 54 | OBSCN | 1.21134307 |
| 55 | STK38L | 1.17604077 |
| 56 | ITK | 1.16600143 |
| 57 | CDK3 | 1.16336535 |
| 58 | MUSK | 1.16295902 |
| 59 | PAK1 | 1.15226854 |
| 60 | HCK | 1.11486957 |
| 61 | PLK2 | 1.11163375 |
| 62 | INSRR | 1.10534226 |
| 63 | DAPK3 | 1.09747747 |
| 64 | TSSK6 | 1.06897895 |
| 65 | STK24 | 1.04927564 |
| 66 | GRK7 | 0.99886081 |
| 67 | MINK1 | 0.97765128 |
| 68 | IRAK3 | 0.96409103 |
| 69 | AKT3 | 0.96217192 |
| 70 | MAPK12 | 0.95208995 |
| 71 | TAOK2 | 0.94960624 |
| 72 | ERBB3 | 0.91368157 |
| 73 | JAK3 | 0.90821137 |
| 74 | PLK3 | 0.90462319 |
| 75 | MARK1 | 0.90032033 |
| 76 | IRAK4 | 0.88820408 |
| 77 | BRD4 | 0.88256924 |
| 78 | PRKCE | 0.85951021 |
| 79 | MAP2K3 | 0.85800002 |
| 80 | EIF2AK2 | 0.82677787 |
| 81 | PDK1 | 0.78995801 |
| 82 | MAP3K3 | 0.78599927 |
| 83 | DYRK1A | 0.77924337 |
| 84 | KIT | 0.76399640 |
| 85 | KSR1 | 0.74560988 |
| 86 | TEC | 0.74085738 |
| 87 | NTRK2 | 0.72623911 |
| 88 | CHEK2 | 0.72057474 |
| 89 | PRKD1 | 0.71904380 |
| 90 | VRK1 | 0.70756145 |
| 91 | TNK2 | 0.69999272 |
| 92 | PINK1 | 0.69924267 |
| 93 | PRKACG | 0.64174124 |
| 94 | ERBB4 | 0.62958149 |
| 95 | PRKCG | 0.61739208 |
| 96 | MAP2K1 | 0.57988071 |
| 97 | CHUK | 0.56965491 |
| 98 | ERBB2 | 0.55299506 |
| 99 | NEK6 | 0.54693146 |
| 100 | MAPK7 | 0.54585350 |
| 101 | FES | 0.54507304 |
| 102 | STK39 | 0.54493510 |
| 103 | MATK | 0.54213647 |
| 104 | DAPK1 | 0.54081806 |
| 105 | PKN1 | 0.54017149 |
| 106 | PDGFRB | 0.53221036 |
| 107 | RET | 0.53109292 |
| 108 | PLK4 | 0.52804367 |
| 109 | CAMK1 | 0.52576686 |
| 110 | IRAK2 | 0.52351915 |
| 111 | ATR | 0.50405989 |
| 112 | PDPK1 | 0.49590149 |
| 113 | NEK9 | 0.49217799 |
| 114 | GRK1 | 0.47919011 |
| 115 | CAMK2A | 0.47429661 |
| 116 | FER | 0.47137705 |
| 117 | DAPK2 | 0.46983642 |
| 118 | IKBKB | 0.46948791 |
| 119 | CSNK1A1 | 0.46609265 |
| 120 | RIPK4 | 0.46342349 |
| 121 | DDR2 | 0.45943553 |
| 122 | SGK1 | 0.45650713 |
| 123 | PRKCQ | 0.44106085 |
| 124 | ADRBK1 | 0.43634890 |
| 125 | RAF1 | 0.43394164 |
| 126 | FYN | 0.43312614 |
| 127 | MAP3K6 | 0.42813037 |
| 128 | PAK3 | 0.41928149 |
| 129 | RPS6KB1 | 0.41602701 |
| 130 | GRK5 | 0.40436841 |
| 131 | MAP3K5 | 0.38190149 |
| 132 | CAMK4 | 0.37844312 |
| 133 | SIK1 | 0.37146058 |
| 134 | PRKG2 | 0.36452191 |
| 135 | EPHA2 | 0.36240422 |
| 136 | CAMKK2 | 0.35759891 |
| 137 | CAMK2G | 0.35096637 |
| 138 | STK4 | 0.34708348 |
| 139 | SYK | 0.32363796 |
| 140 | PRKG1 | 0.31722035 |
| 141 | JAK1 | 0.31709187 |
| 142 | ROCK1 | 0.31706305 |
| 143 | MARK3 | 0.30614424 |
| 144 | CDK7 | 0.30035815 |
| 145 | JAK2 | 0.29829015 |
| 146 | PRKCB | 0.29325739 |
| 147 | IRAK1 | 0.28698955 |
| 148 | TTN | 0.28528995 |
| 149 | PIM2 | 0.27993218 |
| 150 | PRKCD | 0.27918395 |
| 151 | LCK | 0.27614882 |
| 152 | PRKACA | 0.27458206 |
| 153 | PRKCA | 0.27452946 |
| 154 | DMPK | 0.26879448 |
| 155 | PRKD2 | 0.26274301 |
| 156 | BRAF | 0.26025152 |
| 157 | MAP3K13 | 0.25614451 |
| 158 | BCR | 0.25366763 |
| 159 | ATM | 0.23101855 |
| 160 | LYN | 0.22949398 |
| 161 | OXSR1 | 0.22514973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 5.70213223 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.81606357 |
| 3 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 3.38772160 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.83983626 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.67208166 |
| 6 | Taste transduction_Homo sapiens_hsa04742 | 2.45603210 |
| 7 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.44476710 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.40830263 |
| 9 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.36564218 |
| 10 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.35256773 |
| 11 | Gap junction_Homo sapiens_hsa04540 | 2.27579841 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.17222746 |
| 13 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.09545072 |
| 14 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.08626002 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 2.07118726 |
| 16 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.01857144 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.00976634 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.99517015 |
| 19 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.94599832 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.91854382 |
| 21 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.81852629 |
| 22 | GABAergic synapse_Homo sapiens_hsa04727 | 1.75575498 |
| 23 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.65946725 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.62977593 |
| 25 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.57332636 |
| 26 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.56877214 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.56364878 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.45167851 |
| 29 | Alcoholism_Homo sapiens_hsa05034 | 1.39577457 |
| 30 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37885046 |
| 31 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.36343634 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.36049168 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.35977692 |
| 34 | Allograft rejection_Homo sapiens_hsa05330 | 1.34469329 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.29816149 |
| 36 | Insulin secretion_Homo sapiens_hsa04911 | 1.25934707 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.24766653 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.22990689 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.20284237 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.19762898 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.18535972 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17839490 |
| 43 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.16725825 |
| 44 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.15722523 |
| 45 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.15562853 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 1.14849160 |
| 47 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.13241930 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12251166 |
| 49 | Endocytosis_Homo sapiens_hsa04144 | 1.12219991 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.11762339 |
| 51 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11713150 |
| 52 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.10565125 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 1.10132450 |
| 54 | Cocaine addiction_Homo sapiens_hsa05030 | 1.09002677 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.06730019 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.06219899 |
| 57 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05161164 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 1.04958772 |
| 59 | Olfactory transduction_Homo sapiens_hsa04740 | 1.04517818 |
| 60 | Phototransduction_Homo sapiens_hsa04744 | 1.03658516 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.02025649 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.01070711 |
| 63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.00000876 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98440053 |
| 65 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.98287810 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97753187 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 0.97398208 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94965642 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.93381023 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.89987768 |
| 71 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.89044551 |
| 72 | Shigellosis_Homo sapiens_hsa05131 | 0.88817701 |
| 73 | Measles_Homo sapiens_hsa05162 | 0.85527640 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84976935 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.84956629 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84900704 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83572216 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.83103492 |
| 79 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82984492 |
| 80 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82808081 |
| 81 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.80932135 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.80630053 |
| 83 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80533344 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80283596 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.80238046 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80156653 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79923650 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.79731114 |
| 89 | Protein export_Homo sapiens_hsa03060 | 0.79037213 |
| 90 | Axon guidance_Homo sapiens_hsa04360 | 0.77131699 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76202311 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.75572252 |
| 93 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.74464179 |
| 94 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.74279331 |
| 95 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72738414 |
| 96 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.72737551 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72315870 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.71889506 |
| 99 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.70834644 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70775696 |
| 101 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.70073140 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.69556951 |
| 103 | Melanoma_Homo sapiens_hsa05218 | 0.68805740 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.67990820 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.66879860 |
| 106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66485743 |
| 107 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66395809 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65993526 |
| 109 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64926851 |
| 110 | Malaria_Homo sapiens_hsa05144 | 0.64334320 |
| 111 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64193923 |
| 112 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.61875286 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61571307 |
| 114 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58525579 |
| 115 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56955966 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56242174 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55061346 |
| 118 | Tuberculosis_Homo sapiens_hsa05152 | 0.55038339 |
| 119 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.54967927 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54895004 |
| 121 | Glioma_Homo sapiens_hsa05214 | 0.54861600 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.54315415 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.53987778 |
| 124 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52656167 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52623566 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.51583800 |
| 127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51346499 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50936208 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50122544 |
| 130 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50026588 |
| 131 | Purine metabolism_Homo sapiens_hsa00230 | 0.49656295 |
| 132 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.49243936 |
| 133 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47483925 |
| 134 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46391987 |
| 135 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46304313 |
| 136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44689481 |
| 137 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44658281 |
| 138 | RNA polymerase_Homo sapiens_hsa03020 | 0.44430647 |
| 139 | Influenza A_Homo sapiens_hsa05164 | 0.42633438 |
| 140 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.41282656 |
| 141 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41082075 |
| 142 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.40838771 |
| 143 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.39524582 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39229726 |
| 145 | ABC transporters_Homo sapiens_hsa02010 | 0.37873151 |
| 146 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37721410 |
| 147 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37689555 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.37497127 |
| 149 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37149275 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37145360 |
| 151 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.36910582 |
| 152 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36829388 |
| 153 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.35048304 |
| 154 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34634604 |
| 155 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34130853 |
| 156 | Amoebiasis_Homo sapiens_hsa05146 | 0.33645296 |
| 157 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33605934 |
| 158 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33044046 |
| 159 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.32156693 |
| 160 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32108928 |
| 161 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31533009 |
| 162 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.31421640 |
| 163 | Mismatch repair_Homo sapiens_hsa03430 | 0.30959438 |
| 164 | Leishmaniasis_Homo sapiens_hsa05140 | 0.28398894 |

